首页> 外文期刊>Internal medicine journal >Survival and predictors of outcome among patients with decompensated liver disease in a non-liver transplant intensive care unit. Pessimism is historical and unjustified
【24h】

Survival and predictors of outcome among patients with decompensated liver disease in a non-liver transplant intensive care unit. Pessimism is historical and unjustified

机译:非肝移植重症监护单元中失代偿肝病患者结果的存活率和预测。 悲观主义是历史和不合理的

获取原文
获取原文并翻译 | 示例
           

摘要

Background Recent literature emanating from the United Kingdom and United States has reported decreasing mortality rates in patients with decompensated cirrhosis and organ failures presenting to the intensive care unit (ICU). Aim To determine if there were comparable outcomes in a single-centre non-transplant unit in Australia. Methods A retrospective observational study was conducted in a tertiary, non-liver transplant unit in Sydney, Australia. Admission data and mortality outcomes were collected from patients with cirrhosis non-electively admitted to ICU between 2013 and 2017. Liver-specific and general intensive care scoring tools were also assessed for their discriminative ability to predict short-term prognostic outcomes. Results Sixty-three patients were admitted with decompensated liver disease who fulfilled the inclusion criteria. The overall hospital mortality was 37% (95% CI: 0.26-0.49). There was no difference in survival based on aetiology of liver disease (P = 0.96) but a significant difference was found based on the presenting diagnosis, with greater survival among patients diagnosed with hepatic encephalopathy on ICU admission (P = 0.02). There was 4% mortality in patients with no organ failure and 52% mortality in those with >= 3 organs in failure (P < 0.001). The ICU prognostic Sequential Organ Failure Assessment score was the better discriminative tool in predicting short-term outcomes when compared to liver prognostic scores. Conclusion The outcomes of this single-centre Australian study align with current overseas literature. These results reinforce and expand on limited local evidence, corroborating the former universal prognostic pessimism towards cirrhotic patients with organ failure as unwarranted.
机译:背景技术从英国和美国发出的最近文献已经报道了失代偿的肝硬化和器官失败患者的死亡率降低了呈现给重症监护股(ICU)。旨在确定澳大利亚单中心非移植单位中是否存在可比的结果。方法在澳大利亚悉尼的第三次非肝移植单位进行回顾性观察研究。从2013年至2013年间,从肝硬化患者收集肝硬化患者的入学数据和死亡率结果。肝脏特异性和一般性密集的监护者评分工具也被评估了预测短期预后结果的歧视能力。结果六十三名患者患有失代偿的肝病,达到纳入标准。整体医院死亡率为37%(95%CI:0.26-0.49)。基于肝病的疾病的病毒学没有生存差异(p = 0.96),但基于呈现诊断发现显着差异,患有ICU入学患者患者的患者的患者更大的存活率(p = 0.02)。在没有器官衰竭的患者中,没有4%的死亡率和52%的死亡率,= 3器官失败(P <0.001)。 ICU预后顺序器官失败评估评分是预测与肝预后评分相比的短期结果的更好辨别工具。结论该研究与当前的海外文学为准。这些结果在有限的地方证据中加强和扩展,使前一种普遍的预后悲观朝向肝硬化患者与器官衰竭无意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号